Skip to main content
. 2022 Jun 2;9:rbac037. doi: 10.1093/rb/rbac037

Figure 7.

Figure 7.

(a) Custom synthesized nanocomposite (FeNP@MSNs doped with nanoceria) and its utilization in theragnosis of ICH. (b) MRI of ICH brain 5 days after nanocomposite injection. The arrow head points to low signal intensities in the peri-hematomal region, indicating uptake of these nanoparticles by the recruited inflammatory cells. (c) Activated microglia/macrophages in vehicle-treated (left) and nanocomposite-treated (right) groups. Adapted with permission from Ref. [98], Springer Nature 2018.